Core Viewpoint - The company has decided to terminate certain fundraising projects and will continue to store the remaining raised funds in a dedicated account, which is a prudent decision based on the actual implementation of the projects [2][9]. Fundraising Overview - The company raised a total of RMB 709.8 million by issuing 21 million shares at a price of RMB 33.80 per share, with a net amount of RMB 631.94 million after deducting issuance costs of RMB 77.86 million [2][3]. Investment Project Status - The planned investment projects for the raised funds included a total of RMB 291.60 million, with the company approving the termination of the "Radio Testing Simulation Open Laboratory" project and reallocating some surplus funds for working capital [4][7]. Termination of Investment Projects - The "Radio Testing Simulation Open Laboratory" project, originally planned for an investment of RMB 24.59 million, is being postponed until August 2025 due to slow progress influenced by market conditions and the company's business development strategy [5][8]. Reasons for Project Termination - The decision to terminate the project was based on the company's assessment that existing regional laboratories and marketing centers sufficiently meet current business needs, making further investment in the open laboratory unnecessary [7][8]. Use of Surplus Funds - Remaining funds will continue to be stored in the dedicated account for future payments and potential new projects, ensuring compliance with relevant regulations and efficient use of resources [9][10]. Impact of Project Termination - The termination of the project and the decision to store surplus funds are expected to enhance resource allocation and align with the company's long-term development strategy, without adversely affecting normal operations [9][10]. Review Process - The decision has been reviewed and approved by the company's board and will be submitted for shareholder approval, ensuring adherence to legal and regulatory requirements [9][10].

Core Viewpoint - The report outlines the ongoing supervision and compliance of Chengdu Kunheng Shunwei Technology Co., Ltd. (Kunheng Shunwei) following its initial public offering and listing on the Sci-Tech Innovation Board, emphasizing the importance of adherence to regulatory requirements and internal controls [1][2]. Group 1: Continuous Supervision Work - The sponsor has established and effectively implemented a continuous supervision work system for Kunheng Shunwei [1]. - A sponsorship agreement has been signed, clarifying the rights and obligations of both parties during the supervision period [1]. - Continuous supervision includes daily communication, regular visits, on-site inspections, and due diligence [1][2]. Group 2: Compliance and Internal Controls - Kunheng Shunwei is required to establish and effectively execute corporate governance systems, including rules for shareholder meetings, board meetings, and management behavior [1]. - The company has built an internal control system in accordance with the Shanghai Stock Exchange's regulations, focusing on financial management, accounting, and auditing [1][2]. Group 3: Financial Performance - For the first half of 2025, the company reported operating revenue of approximately 102.36 million yuan, a 26.69% increase compared to the same period in 2024 [10]. - The total profit for the same period was approximately 12.00 million yuan, reflecting a 1.04% increase from the previous year [10]. - The net profit attributable to shareholders decreased by 8.49% to approximately 12.81 million yuan [10]. Group 4: Research and Development - The total R&D expenditure for the first half of 2025 was approximately 30.62 million yuan, a 2.22% increase from the same period in 2024 [14]. - The company holds 23 invention patents and 43 software copyrights as of June 30, 2025 [15][14]. Group 5: Risks and Challenges - The company faces risks related to the loss of core technical personnel, which could impact its competitive position [5]. - There is a risk of core technology leakage if confidentiality measures are not maintained [5]. - Seasonal fluctuations in revenue and profit levels are noted, with the second half of the year typically generating higher income [5]. Group 6: Shareholder and Management Structure - As of June 30, 2025, the major shareholders include the chairman and core technical personnel, holding significant stakes in the company [18]. - There have been no significant changes in shareholding or pledging among key management personnel during the reporting period [18].

Core Viewpoint - Chengdu Kunheng Shunwei Technology Co., Ltd. plans to terminate part of its fundraising projects, specifically the "Radio Testing Simulation Open Laboratory," and will continue to store the remaining raised funds in a dedicated account for future use [6][12][14]. Group 1: Meeting Arrangements - The company has established guidelines for the shareholder meeting to ensure order and efficiency, including identity verification for attendees [1][2]. - Shareholders must sign in and present necessary documentation before the meeting starts [2][5]. - The meeting will follow a predetermined agenda for discussing and voting on proposals [3][7]. Group 2: Proposal Details - The project to be terminated, "Radio Testing Simulation Open Laboratory," had an initial investment plan of 24.5898 million yuan and was intended to establish five laboratories across major cities [6][9]. - The project has seen a 27.22% investment progress, with 1.4443 million yuan still required for outstanding payments [9][10]. - The decision to terminate the project is based on a reassessment of market conditions and the company's current operational needs [10][11]. Group 3: Future Fund Management - Remaining funds from the terminated project will be stored in a dedicated account and used for future projects that align with the company's business needs [12]. - The company will conduct thorough feasibility analyses for any new investment projects to ensure they meet market demands and operational necessities [12][13]. - The decision to terminate the project and manage funds accordingly is deemed beneficial for resource allocation and aligns with the company's long-term development strategy [12][14].

证券代码：688283 证券简称：坤恒顺维 公告编号：2025-048 成都坤恒顺维科技股份有限公司 （三） 投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025 年 9 月 11 日 至2025 年 9 月 11 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过互联网 投票平台的投票时间为股东会召开当日的 9:15-15:00。 （六） 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者的投 票，应按照《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》 等有关规定执行。 （七） 涉及公开征集股东投票权 关于召开2025年第二次临时股东会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 股东会召开 ...

Core Viewpoint - Chengdu Kunheng Shunwei Technology Co., Ltd. has decided to terminate the investment project "Radio Testing Simulation Open Laboratory" and will continue to store the remaining raised funds of 18.6352 million yuan in a special account for raised funds, based on a comprehensive consideration of the actual implementation of the investment projects [1][2][9]. Summary by Sections 1. Basic Situation of Raised Funds - The company issued 21 million shares at a price of 77,857,477.96 yuan, with a net raised fund of 631,942,522.04 yuan, all of which have been received [2][3]. 2. Investment Project Situation - The total planned investment for the raised funds was 291.5988 million yuan, with the project "Radio Testing Simulation Open Laboratory" originally planned for 24 months [3][5]. 3. Termination of Investment Project - The project "Radio Testing Simulation Open Laboratory" was planned with an investment of 24.5898 million yuan, but due to slow progress and changes in market conditions, the company has decided to terminate it [5][7][8]. 4. Reasons for Termination - The project faced slow construction progress due to changes in business development plans and market environment. The existing regional open laboratories and marketing centers are deemed sufficient for current business needs [7][8]. - The equipment planned for demonstration in the open laboratories has become outdated due to rapid product updates, necessitating a shift to self-funded investments for new demonstration equipment [8] . 5. Future Use of Remaining Funds - The remaining funds will be stored in the special account for raised funds and will be used for future projects that align with the company's main business [9][10]. 6. Impact of the Termination - The decision to terminate the project is seen as beneficial for resource allocation and aligns with the company's long-term development plan, ensuring no adverse impact on normal operations [9][10]. 7. Review Procedures - The decision has been approved by the board and requires shareholder meeting approval, with the sponsor institution providing a favorable review [10].

证券代码：688283 证券简称：坤恒顺维 公告编号：2025-045 成都坤恒顺维科技股份有限公司 情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据《上市公司募集资金监管规则》《上海证券交易所科创板上市公司自律 监管指引第 1 号——规范运作》及相关格式指引的要求，成都坤恒顺维科技股份 有限公司（以下简称"公司"、"本公司"或"坤恒顺维"）董事会现将公司 2025 年半年度募集资金存放、管理与实际使用情况专项报告如下： 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 经中国证券监督管理委员会《关于同意成都坤恒顺维科技股份有限公司首次 公开发行股票的批复》（证监许可〔2022〕9 号）核准，并经上海证券交易所同意， 公司向社会公众公开发行人民币普通股（A 股）股票 2,100 万股，发行价格 33.80 元/股，共募集资金总额为人民币 709,800,000.00 元，减除发行费用（不含增值税） 人民币 77,857,477.96 元，募集资金净额为人民币 631,942,522.04 元。 ...

Core Viewpoint - Chengdu Kunheng Shunwei Technology Co., Ltd. is committed to enhancing operational quality and investor returns through its 2025 "Quality Improvement and Efficiency Enhancement" action plan, with a focus on core business development and governance optimization [1][11]. Group 1: Business Performance - In the first half of 2025, the company achieved operating revenue of 102.36 million yuan, a year-on-year increase of 26.69%, while net profit attributable to shareholders decreased by 8.49% to 12.81 million yuan [1]. - The second quarter of 2025 saw a revenue growth of 23.44%, indicating a steady improvement in operational conditions [1]. Group 2: Product Development and Market Demand - The company experienced a structural breakthrough in high-end testing instrument sales due to the release of autonomous controllable demands and accelerated upgrades of research equipment by downstream users [2]. - New products, including the next-generation channel simulator and spectrum analyzer, have been successfully validated in the market, leading to rapid revenue growth [2][3]. - The satellite communication industry has driven increased demand for simulation and testing instruments, contributing to new growth momentum for the company [3]. Group 3: Research and Development - R&D expenses amounted to 30.62 million yuan, accounting for 29.91% of operating revenue, reflecting a year-on-year increase of 2.22% [3]. - The company is continuously optimizing core product functions and developing new products to strengthen its long-term strategic layout [3][4]. Group 4: Governance and Compliance - The company has improved its governance structure and internal control systems, including the adjustment of internal supervisory institutions and the revision of its articles of association [6][7]. - The board of directors has been restructured to enhance governance levels and operational capabilities [6][7]. Group 5: Shareholder Returns - The company has implemented a share repurchase plan, buying back 851,910 shares, which is 0.70% of the total share capital, with a total expenditure of approximately 16.30 million yuan [8][9]. - A cash dividend of 84.91% of the net profit attributable to shareholders was proposed for distribution to shareholders [9]. Group 6: Investor Relations - The company emphasizes effective information disclosure and investor relations management, participating in various investor communication activities to enhance transparency and trust [10]. - The company has established multiple communication channels to provide investors with insights into its operations and market dynamics [10]. Group 7: Future Outlook - The company plans to continue focusing on its core business, enhancing competitiveness, and maintaining technological leadership while ensuring investor interests are protected [11].

Summary of Key Points Core Viewpoint - The company announced a provision for asset impairment totaling 4.4018 million yuan for the second quarter of 2025, reflecting a cautious approach to accurately represent its financial status and operational results as of June 30, 2025 [1][4]. Group 1: Asset Impairment Provision Details - The company recognized total asset impairment losses of 4.4018 million yuan for the second quarter of 2025, with specific breakdowns including: - Bad debt losses on accounts receivable amounting to 6.3829 million yuan and bad debt losses on notes receivable of 2.0905 million yuan [3]. - Other receivables had a bad debt provision of 0.0588 million yuan, and contract asset impairment losses were recorded at 0.0506 million yuan [3][4]. - The total credit impairment loss recognized was 2.0905 million yuan, while other receivables accounted for 0.0588 million yuan in bad debt provisions [3]. Group 2: Impact on Financial Statements - The asset impairment provision will be reflected in the credit impairment loss and asset impairment loss accounts, impacting the company's consolidated profit before tax by 4.4018 million yuan for the second quarter of 2025 [4]. - The provision is in accordance with the relevant accounting standards and is intended to fairly represent the company's asset value and financial condition [4].

Group 1 - The company reported a revenue of 102,359,904.48 yuan for the first half of 2025, representing a year-on-year increase of 26.69% [2] - The net profit attributable to shareholders of the listed company was 12,811,937.27 yuan, showing a year-on-year decrease of 8.49% [2]

Group 1 - The company Kunhengshunwei announced that it will hold its second extraordinary general meeting of shareholders for 2025 on September 11, 2025 [1] - The agenda for the meeting includes the review of a proposal regarding the termination of certain fundraising projects and the continuation of the remaining raised funds in a special account [1]